FDA recall record

Jubilant Cadista Pharmaceuticals Methylprednisolone Tablets USP, 4 MG recall — FDA D-0298-2021

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Class IIIclassification
D-0298-2021official record ID
Mar 10, 2021report date

Recall record at a glance

Official recordD-0298-2021
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmJubilant Cadista Pharmaceuticals, Inc.
Report dateMar 10, 2021
Recall initiation dateFeb 19, 2021
Quantity635,400 cartons
LocationSalisbury, MD, United States

Official product description

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

Why the product was recalled

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Distribution information

USA nationwide, including Puerto Rico.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.